International Journal of Tuberculosis and Lung Disease

Papers
(The H4-Index of International Journal of Tuberculosis and Lung Disease is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-08-01 to 2024-08-01.)
ArticleCitations
The impact of COVID-19 on TB: a review of the data174
Post-tuberculosis lung health: perspectives from the First International Symposium107
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease73
The Global Asthma Report 202269
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-1969
Impact of COVID-19 on TB diagnosis in Northeastern Brazil44
COVID-19 and tuberculosis—threats and opportunities40
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria37
Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China36
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review36
Clinical standards for the diagnosis, treatment and prevention of TB infection33
Post-TB health and wellbeing32
The COVID-19 and TB syndemic: the way forward31
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB30
Clinical standards for the dosing and management of TB drugs28
Adapting TB services during the COVID-19 pandemic in Mumbai, India25
Post-tuberculosis sequelae: the need to look beyond treatment outcome24
The burden and determinants of post-TB lung disease24
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function23
Diagnosing pulmonary aspergillosis is much easier than it used to be: a new diagnostic landscape23
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic23
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities22
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?22
Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid22
0.049268007278442